Revisión crítica del ensayo clínico HEAAL (Efecto del losartan a dosis alta frente a dosis baja en pacientes con insuficiencia cardíaca)
Leído
4368
Vecesse ha leído el artículo
2524
Total PDF
1844
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 10 | 30 | 40 |
| 2025 11 | 14 | 89 | 103 |
| 2025 10 | 11 | 46 | 57 |
| 2025 9 | 8 | 29 | 37 |
| 2025 8 | 13 | 52 | 65 |
| 2025 7 | 11 | 26 | 37 |
| 2025 6 | 10 | 26 | 36 |
| 2025 5 | 8 | 20 | 28 |
| 2025 4 | 10 | 17 | 27 |
| 2025 3 | 12 | 30 | 42 |
| 2025 2 | 16 | 24 | 40 |
| 2025 1 | 20 | 32 | 52 |
| 2024 12 | 6 | 28 | 34 |
| 2024 11 | 7 | 23 | 30 |
| 2024 10 | 6 | 23 | 29 |
| 2024 9 | 8 | 34 | 42 |
| 2024 8 | 7 | 34 | 41 |
| 2024 7 | 6 | 28 | 34 |
| 2024 6 | 12 | 48 | 60 |
| 2024 5 | 15 | 31 | 46 |
| 2024 4 | 14 | 19 | 33 |
| 2024 3 | 12 | 36 | 48 |
| 2024 2 | 12 | 34 | 46 |
| 2024 1 | 15 | 29 | 44 |
| 2023 12 | 27 | 20 | 47 |
| 2023 11 | 25 | 36 | 61 |
| 2023 10 | 25 | 37 | 62 |
| 2023 9 | 18 | 24 | 42 |
| 2023 8 | 23 | 26 | 49 |
| 2023 7 | 22 | 45 | 67 |
| 2023 6 | 29 | 81 | 110 |
| 2023 5 | 18 | 47 | 65 |
| 2023 4 | 9 | 27 | 36 |
| 2023 3 | 5 | 21 | 26 |
| 2023 2 | 6 | 10 | 16 |
| 2022 1 | 16 | 13 | 29 |
| 2022 12 | 13 | 28 | 41 |
| 2022 11 | 15 | 17 | 32 |
| 2022 10 | 20 | 27 | 47 |
| 2022 9 | 12 | 27 | 39 |
| 2022 8 | 19 | 23 | 42 |
| 2022 7 | 14 | 25 | 39 |
| 2022 6 | 9 | 27 | 36 |
| 2022 5 | 13 | 17 | 30 |
| 2022 4 | 12 | 16 | 28 |
| 2022 3 | 15 | 26 | 41 |
| 2022 2 | 19 | 12 | 31 |
| 2021 1 | 23 | 4 | 27 |
| 2021 12 | 9 | 17 | 26 |
| 2021 11 | 6 | 17 | 23 |
| 2021 10 | 12 | 20 | 32 |
| 2021 9 | 7 | 16 | 23 |
| 2021 8 | 3 | 25 | 28 |
| 2021 7 | 8 | 9 | 17 |
| 2021 6 | 8 | 8 | 16 |
| 2021 5 | 9 | 26 | 35 |
| 2021 4 | 23 | 33 | 56 |
| 2021 3 | 10 | 30 | 40 |
| 2021 2 | 18 | 21 | 39 |
| 2020 1 | 9 | 24 | 33 |
| 2020 12 | 13 | 21 | 34 |
| 2020 11 | 4 | 17 | 21 |
| 2020 10 | 6 | 14 | 20 |
| 2020 9 | 5 | 9 | 14 |
| 2020 8 | 8 | 12 | 20 |
| 2020 7 | 7 | 12 | 19 |
| 2020 6 | 5 | 15 | 20 |
| 2020 5 | 6 | 13 | 19 |
| 2020 4 | 4 | 15 | 19 |
| 2020 3 | 1 | 6 | 7 |
| 2020 2 | 0 | 3 | 3 |
| 2020 1 | 0 | 4 | 4 |
| 2019 12 | 0 | 6 | 6 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 0 | 2 | 2 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 3 | 3 |
| 2019 6 | 0 | 6 | 6 |
| 2019 5 | 0 | 30 | 30 |
| 2019 4 | 0 | 7 | 7 |
| 2019 3 | 0 | 1 | 1 |
| 2019 2 | 0 | 4 | 4 |
| 2018 7 | 0 | 1 | 1 |
| 2018 5 | 1 | 9 | 10 |
| 2018 4 | 6 | 23 | 29 |
| 2018 3 | 0 | 18 | 18 |
| 2018 2 | 2 | 15 | 17 |
| 2018 1 | 7 | 27 | 34 |
| 2017 12 | 1 | 13 | 14 |
| 2017 11 | 4 | 22 | 26 |
| 2017 10 | 4 | 18 | 22 |
| 2017 9 | 4 | 19 | 23 |
| 2017 8 | 9 | 7 | 16 |
| 2017 7 | 7 | 5 | 12 |
| 2017 6 | 5 | 13 | 18 |
| 2017 5 | 5 | 6 | 11 |
| 2017 4 | 6 | 5 | 11 |
| 2017 3 | 20 | 8 | 28 |
| 2017 2 | 23 | 4 | 27 |
| 2016 1 | 6 | 12 | 18 |
| 2016 12 | 22 | 13 | 35 |
| 2016 11 | 20 | 13 | 33 |
| 2016 10 | 26 | 8 | 34 |
| 2016 9 | 21 | 23 | 44 |
| 2016 8 | 18 | 5 | 23 |
| 2016 7 | 8 | 1 | 9 |
| 2016 6 | 7 | 24 | 31 |
| 2016 5 | 6 | 22 | 28 |
| 2016 4 | 0 | 28 | 28 |
| 2016 3 | 7 | 22 | 29 |
| 2016 2 | 7 | 24 | 31 |
| 2015 1 | 10 | 25 | 35 |
| 2015 12 | 4 | 16 | 20 |
| 2015 11 | 12 | 17 | 29 |
| 2015 10 | 18 | 23 | 41 |
| 2015 9 | 12 | 15 | 27 |
| 2015 8 | 7 | 8 | 15 |
| 2015 7 | 7 | 11 | 18 |
| 2015 6 | 4 | 13 | 17 |
| 2015 5 | 3 | 7 | 10 |
| 2015 4 | 12 | 15 | 27 |
| 2015 3 | 12 | 9 | 21 |
| 2015 2 | 15 | 8 | 23 |
| 2015 1 | 11 | 3 | 14 |
| 2014 12 | 15 | 7 | 22 |
| 2014 11 | 24 | 2 | 26 |
| 2014 10 | 26 | 2 | 28 |
| 2014 9 | 24 | 2 | 26 |
| 2014 8 | 13 | 3 | 16 |
| 2014 7 | 28 | 3 | 31 |
| 2014 6 | 14 | 2 | 16 |
| 2014 5 | 22 | 4 | 26 |
| 2014 4 | 12 | 4 | 16 |
| 2014 3 | 23 | 4 | 27 |
| 2014 2 | 15 | 2 | 17 |
| 2014 1 | 18 | 3 | 21 |
| 2013 12 | 24 | 4 | 28 |
| 2013 11 | 22 | 5 | 27 |
| 2013 10 | 30 | 8 | 38 |
| 2013 9 | 23 | 7 | 30 |
| 2013 8 | 15 | 7 | 22 |
| 2013 7 | 12 | 4 | 16 |
| 2010 3 | 254 | 0 | 254 |
Mostrar todo
